The In Silico Modeling and Simulation Conference to Enable Healthcare Innovation 

29 - 30 March, 2022 | Online Event

Liesbet Geris

Executive Director Virtual Physiological Human Institute (VPHi)

Liesbet Geris is Professor in Biomechanics and Computational Tissue Engineering at the university of Liège and KU Leuven in Belgium. Her research focusses on the multi-scale and multi-physics modeling of biological processes. Together with her team and their clinical and industrial collaborators, she uses these models to investigate the etiology of non-healing fractures, to design in silico potential cell-based treatment strategies and to optimize manufacturing processes of these tissue engineering constructs. Liesbet is scientific coordinator of the Prometheus platform for Skeletal Tissue Engineering (50+ researchers). She has edited several books on computational modeling and tissue engineering. She has received 2 prestigious ERC grants (starting in 2011 and consolidator in 2017) to finance her research and has received a number of young investigator and research awards from the in silico and regenerative medicine communities. She is a former member and chair of the Young Academy of Belgium (Flanders) and member of the strategic alliance committee of the Tissue Engineering and Regenerative Medicine Society. She is the current executive director of the Virtual Physiological Human Institute and in that capacity she advocates the use of in silico modeling in healthcare through liaising with the clinical community, the European Commission and Parliament, regulatory agencies (EMA, FDA) and various other stakeholders. Besides her research work, she is often invited to give public lectures on the challenges of interdisciplinarity in research, women in academia and digital healthcare.

Conference Day Two: Pharmaceuticals

11:00 AM The Process to Adopt and Deploy

The importance of adopting in silico methods has become obvious, and pharmaceutical leaders are looking for the most efficient ways to adopt this technology quickly while minimizing risk and uncertainty. In silico veterans, including executives from Amgen, CEO of startup company Antleron, technical leaders from Ansys, and an academic thought leader will discuss the importance of an ecosystem and their recommendations for the successful adoption of CM&S during this prestigious panel discussion chaired by Ansys CTO, Prith Banerjee.

Check out the incredible speaker line-up to see who will be joining Liesbet.

Download The Latest Agenda